We reported that Neuronal Pentraxin 2 (NPTX2), a secreted synaptic protein that mediates homeostatic adaptation to increased excitability by enhancing inhibitory synaptic circuits [17,18], is markedly decreased in postmortem brain lysates and in CSF in MCI and AD [19]. This evidence concerns the gene NPTX2 and Alzheimer disease.